HER2/NEU POSITIVE
Clinical trials for HER2/NEU POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HER2/NEU POSITIVE trials appear
Sign up with your email to follow new studies for HER2/NEU POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shrinks breast tumors before surgery, study shows
Disease control OngoingThis study tested whether adding trastuzumab to standard chemotherapy before surgery helps shrink breast tumors more effectively. About 92 women with early-stage breast cancer (some HER2-positive, some HER2-negative) took part. The goal was to see if the combination reduces the a…
Matched conditions: HER2/NEU POSITIVE
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New drug Z-Endoxifen shows promise in early breast cancer trial
Disease control OngoingThis early-phase study tested a drug called Z-endoxifen in 62 women with a type of breast cancer that has spread or come back. The goal was to find the safest dose and see how well it blocks estrogen, which can fuel cancer growth. Participants had estrogen receptor-positive (ER+)…
Matched conditions: HER2/NEU POSITIVE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:53 UTC